These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 14759987)

  • 1. Mobilization of dendritic cell precursors into the circulation by administration of MIP-1alpha in mice.
    Zhang Y; Yoneyama H; Wang Y; Ishikawa S; Hashimoto S; Gao JL; Murphy P; Matsushima K
    J Natl Cancer Inst; 2004 Feb; 96(3):201-9. PubMed ID: 14759987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIP-3alpha and MIP-1alpha rapidly mobilize dendritic cell precursors into the peripheral blood.
    He S; Cao Q; Yoneyama H; Ge H; Zhang Y; Zhang Y
    J Leukoc Biol; 2008 Dec; 84(6):1549-56. PubMed ID: 18791167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
    Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
    J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine and chemokine receptor expression by liver-derived dendritic cells: MIP-1alpha production is induced by bacterial lipopolysaccharide and interaction with allogeneic T cells.
    Drakes ML; Zahorchak AF; Takayama T; Lu L; Thomson AW
    Transpl Immunol; 2000 Mar; 8(1):17-29. PubMed ID: 10834607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
    Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
    Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of MIP-1alpha-recruited dendritic cells on preestablished solid and metastatic tumors.
    Cao Q; Jin Y; Jin M; He S; Gu Q; He S; Qiu Y; Ge H; Yoneyama H; Zhang Y
    Cancer Lett; 2010 Sep; 295(1):17-26. PubMed ID: 20202744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
    Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant myelopoietic effector functions mediated by chemokine receptor CCR1.
    Broxmeyer HE; Cooper S; Hangoc G; Gao JL; Murphy PM
    J Exp Med; 1999 Jun; 189(12):1987-92. PubMed ID: 10377195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL3/MIP-1alpha is pro-inflammatory in murine T cell-mediated hepatitis by recruiting CCR1-expressing CD4(+) T cells to the liver.
    Ajuebor MN; Hogaboam CM; Le T; Proudfoot AE; Swain MG
    Eur J Immunol; 2004 Oct; 34(10):2907-18. PubMed ID: 15368307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells.
    Chen Z; Moyana T; Saxena A; Warrington R; Jia Z; Xiang J
    Int J Cancer; 2001 Aug; 93(4):539-48. PubMed ID: 11477558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization.
    Coates PT; Colvin BL; Ranganathan A; Duncan FJ; Lan YY; Shufesky WJ; Zahorchak AF; Morelli AE; Thomson AW
    Kidney Int; 2004 Nov; 66(5):1907-17. PubMed ID: 15496162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous administration of MIP-1alpha with intra-tumor injection of P. acnes shows potent anti-tumor effect.
    Nakano A; Yoneyama H; Ueha S; Kitabatake M; Ishikawa S; Kawase I; Sugiyama H; Matsushima K
    Int Immunopharmacol; 2007 Jun; 7(6):845-57. PubMed ID: 17466918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages.
    Kaufmann A; Salentin R; Gemsa D; Sprenger H
    J Leukoc Biol; 2001 Feb; 69(2):248-52. PubMed ID: 11272275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5.
    Zoffmann S; Turcatti G; Galzi J; Dahl M; Chollet A
    J Med Chem; 2001 Jan; 44(2):215-22. PubMed ID: 11170631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum amyloid A chemoattracts immature dendritic cells and indirectly provokes monocyte chemotaxis by induction of cooperating CC and CXC chemokines.
    Gouwy M; De Buck M; Pörtner N; Opdenakker G; Proost P; Struyf S; Van Damme J
    Eur J Immunol; 2015 Jan; 45(1):101-12. PubMed ID: 25345597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased responsiveness of murine eosinophils to MIP-1beta (CCL4) and TCA-3 (CCL1) is mediated by their specific receptors, CCR5 and CCR8.
    Oliveira SH; Lira S; Martinez-A C; Wiekowski M; Sullivan L; Lukacs NW
    J Leukoc Biol; 2002 Jun; 71(6):1019-25. PubMed ID: 12050188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte macrophage colony-stimulating factor and interleukin-3 regulate chemokine and chemokine receptor expression in bone marrow macrophages.
    Jarmin DI; Nibbs RJ; Jamieson T; de Bono JS; Graham GJ
    Exp Hematol; 1999 Dec; 27(12):1735-45. PubMed ID: 10641591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1alpha by interacting mainly with a C-C chemokine receptor, CCR1.
    Su S; Mukaida N; Wang J; Zhang Y; Takami A; Nakao S; Matsushima K
    Blood; 1997 Jul; 90(2):605-11. PubMed ID: 9226160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host absence of CCR5 potentiates dendritic cell vaccination.
    Ng-Cashin J; Kuhns JJ; Burkett SE; Powderly JD; Craven RR; van Deventer HW; Kirby SL; Serody JS
    J Immunol; 2003 Apr; 170(8):4201-8. PubMed ID: 12682253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
    Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
    J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.